Global Patent Index - EP 1086130 A1

EP 1086130 A1 2001-03-28 - INSULIN ANALOGUE

Title (en)

INSULIN ANALOGUE

Title (de)

INSULIN ANALOGE

Title (fr)

ANALOGUE DE L'INSULINE

Publication

EP 1086130 A1 (EN)

Application

EP 98928469 A

Priority

GB 9801722 W

Abstract (en)

[origin: WO9965941A1] A novel analogue of insulin has covalently conjugated thereto, preferably at the B1 residue, 3,3',5'-triiodothyroxine. The conjugate is believed to be hepatoselective, whilst it retains insulin receptor binding properties.

IPC 1-7 (main, further and additional classification)

C07K 14/62; A61K 38/17

IPC 8 full level (invention and additional information)

A61K 38/28 (2006.01); A61P 3/10 (2006.01); C07K 14/62 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C07K 14/62 (2013.01); A61K 38/00 (2013.01)

Citation (search report)

See references of WO 9965941A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9965941 A1 19991223; AU 8029798 A 20000105; CA 2334859 A1 19991223; EP 1086130 A1 20010328; JP 2002518408 A 20020625

INPADOC legal status


2004-11-10 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20040415

2002-01-16 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: BTG INTERNATIONAL LIMITED

2001-03-28 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010109

2001-03-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE